Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus Clausii in Irritable Bowel Syndrome
NCT03359499Phase 3Completed
- Sponsor
- Hospital Británico de Buenos Aires
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bacillus clausii in irritable bowel syndrome (IBS), sponsored by Hospital Británico de Buenos Aires. Started Aug 2017; status: completed.
02
Drugs
bacillus clausii
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03359499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359499.